Aliases:This biomarker is also known as:
- Mitogen-activated protein kinase phosphatase 4,
- serine/threonine specific protein phosphatase,
- MAP kinase phosphatase 4,
- EC 126.96.36.199,EC 188.8.131.52,
- map kinase phosphatase 4,
- dual specificity phosphatase 9,
- dual specificity protein phosphatase 9,
- mitogen-activated protein kinase phosphatase 4,
DUSP9 is a member of the dual specificity protein phosphatase subfamily. DUSP9 is specific for members of the ERK family of MAP kinases, is expressed only in placenta, kidney, and fetal liver, and is localized to the cytoplasm and nucleus.
There are no datasets associated with this biomarker.
The following organs have data associated with this biomarker…
|QA State:||Under Review|
No additional breast data available.
DUSP9 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.
- Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study.
- Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased.
- HGNC entry for DUSP9 from Genenames
- KEGG entry for DUSP9 from Genome.jp
- Entrez entry for DUSP9 all NCBI Databasese
- Human GEO Profiles for DUSP9 from NCBI GEO Profiles
- Human Geo Datasets containing term DUSP9 from NCBI GEO Datasets
- GWAS Study Datasets containing gene DUSP9 from GWAS
- Human Single Nucleotide Polymorphisms info for DUSP9
- Human Gene(s) with 'DUSP9' as Gene Name/Alias
- Human Gene RefSeq for DUSP9 from NCBI
- GeneCards entry for human DUSP9
- UniProtKB/Swiss-Prot entry for DUSP9 from Uniprot
- Human Protein RefSeq for DUSP9 from NCBI
- FDA web page describing approval of DUSP9
|UniProt Accession #:||Q99956|
|Mutated Sites Count:||34|
|Associated Pubmed ID Count||0|
|Affected Protein Function Sites Count:||3|